Key result
NAFLD affects ~70% of type 2 diabetics and is linked to more cardiovascular disease.
Why the study?
Nonalcoholic fatty liver disease is highly prevalent in type 2 diabetes and its association with cardiovascular disease requires clarification.
We appreciate the comments by Schindhelm et al. (1) regarding our recent article reporting the prevalence of nonalcoholic fatty liver disease (NAFLD) and its association with cardiovascular disease (CVD) in a type 2 diabetic population (2). In that study, we found that NAFLD is extremely common in type 2 diabetes and is associated with a higher frequency of manifest CVD. The prevalence of NAFLD was 69.5% among participants, and NAFLD was the most common cause (81.5%) of hepatic steatosis on ultrasound. In contrast, the frequency of hepatic steatosis likely due to other nonalcoholic …
No takes yet. Share an insight, caveat, or question.
Targher et al. (2007) conducted a letter in Type 2 diabetes. Nonalcoholic fatty liver disease (NAFLD) was evaluated on Prevalence of NAFLD and association with cardiovascular disease. Among type 2 diabetic patients, NAFLD prevalence was 69.5% and was associated with a higher frequency of manifest cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: